Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Jan 28, 2025, 4:00 PM EST
Oncotelic Therapeutics Revenue
In the year 2023, Oncotelic Therapeutics had annual revenue of $70.00K.
Revenue
70.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
11.08M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| SANUWAVE Health | 29.30M |
Oncotelic Therapeutics News
- 4 weeks ago - Oncotelic Therapeutics Implements PDAOAI Platform - GlobeNewsWire
- 2 months ago - ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024 - GlobeNewsWire
- 6 months ago - Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence - GlobeNewsWire
- 8 months ago - ONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY - GlobeNewsWire
- 8 months ago - ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING - GlobeNewsWire
- 9 months ago - ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING - GlobeNewsWire
- 9 months ago - Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc. - Accesswire
- 11 months ago - Linkage of Cancer and Lupus in Gliomas Patients - GlobeNewsWire